Inventor
JOHNSON JAMES ANDREW
GB15 patents
⚠️ This page may combine multiple inventors who share the name “JOHNSON JAMES ANDREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UCB BIOPHARMA SPRL
5 patentsUS9969728B2May 15, 2018
Tetrahydroimidazopyridine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL14 citations82
US9550737B2Jan 24, 2017
TNF -α modulating benzimidazoles
UCB BIOPHARMA SPRL4 citations71
US10202405B2Feb 12, 2019
Fused pentacyclic imidazole derivatives
UCB BIOPHARMA SPRL4 citations70
US9309243B2Apr 12, 2016
Imidazopyridine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL4 citations68
US10287299B2May 14, 2019
Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity
UCB BIOPHARMA SPRL1 citations56
UCB Biopharma SRL
5 patentsUS10906919B2Feb 2, 2021
Fused pentacyclic imidazole derivatives
UCB Biopharma SRL2 citations70
US11912721B2Feb 27, 2024
Fused pentacyclic imidazole derivatives
UCB Biopharma SRL0 citations60
US10980814B2Apr 20, 2021
Fused pentacyclic imidazole derivatives as modulators of TNF activity
UCB Biopharma SRL0 citations60
US11554122B2Jan 17, 2023
Fused pentacyclic imidazole derivatives as modulators of TNF activity
UCB Biopharma SRL0 citations58
US10953019B2Mar 23, 2021
Fused pentacyclic imidazole derivatives as modulators of TNF activity
UCB Biopharma SRL0 citations51